Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Sangamo Therapeutics (SGMO)

Sangamo Therapeutics (SGMO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 961,838
  • Shares Outstanding, K 115,675
  • Annual Sales, $ 84,450 K
  • Annual Income, $ -68,330 K
  • 60-Month Beta 2.81
  • Price/Sales 11.82
  • Price/Cash Flow N/A
  • Price/Book 2.23

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.33
  • Number of Estimates 5
  • High Estimate -0.28
  • Low Estimate -0.38
  • Prior Year -0.13
  • Growth Rate Est. (year over year) -153.85%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.70 +7.99%
on 10/10/19
10.97 -24.20%
on 09/20/19
-2.46 (-22.79%)
since 09/18/19
3-Month
7.70 +7.99%
on 10/10/19
12.49 -33.43%
on 07/31/19
-3.84 (-31.56%)
since 07/18/19
52-Week
6.26 +32.83%
on 02/07/19
14.58 -42.97%
on 10/19/18
-5.88 (-41.40%)
since 10/18/18

Most Recent Stories

More News
Sangamo Therapeu Set to Possibly Rebound After Yesterday's Selloff of 1.09%

Sangamo Therapeu (NASDAQ:SGMO) traded in a range yesterday that spanned from a low of $8.16 to a high of $8.40. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $8.23...

SGMO : 8.31 (-3.65%)
Look for Shares of Sangamo Therapeu to Potentially Rebound after Yesterday's 3.48% Sell Off

Sangamo Therapeu (NASDAQ:SGMO) traded in a range yesterday that spanned from a low of $8.24 to a high of $8.70. Yesterday, the shares fell 3.5%, which took the trading range below the 3-day low of $8.31...

SGMO : 8.31 (-3.65%)
Sangamo Therapeutics Appoints Bettina M. Cockroft, MD, MBA, as Senior Vice President and Chief Medical Officer

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today the appointment of Bettina M. Cockroft, MD, MBA, as Senior Vice President and Chief Medical Officer. Dr. Cockroft...

SGMO : 8.31 (-3.65%)
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that members of the management team will present at the following investor and industry conferences in October:

SGMO : 8.31 (-3.65%)
Interesting SGMO Put And Call Options For January 2022

Investors in Sangamo Therapeutics Inc saw new options become available this week, for the January 2022 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is...

SGMO : 8.31 (-3.65%)
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will present at the following investor conferences in September:

MS : 43.66 (+0.51%)
WFC : 49.97 (+0.73%)
SGMO : 8.31 (-3.65%)
Sangamo Therapeu Falls 1.09% on Heavy Volume: Watch For Potential Rebound

Sangamo Therapeu (NASDAQ:SGMO) traded in a range yesterday that spanned from a low of $10.77 to a high of $11.25. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of...

SGMO : 8.31 (-3.65%)
Sangamo Therapeutics (SGMO) Reports Q2 Loss, Lags Revenue Estimates

Sangamo (SGMO) delivered earnings and revenue surprises of 25.71% and -9.36%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

SGMO : 8.31 (-3.65%)
Sangamo Therapeutics Reports Second Quarter 2019 Financial Results

Sangamo Therapeutics, Inc. (NASDAQ: SGMO), a genomic medicine company, today reported second quarter 2019 financial results and recent business highlights.

SGMO : 8.31 (-3.65%)
Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that CEO Sandy Macrae will present at the 2019 Wedbush PacGrow Healthcare Conference in New York City. The presentation...

SGMO : 8.31 (-3.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Good. Long term indicators fully support a continuation of the trend.

See More Share

Trade SGMO with:

Business Summary

Sangamo Therapeutics, Inc. is a biotechnology company. It focuses on research and development of genomic therapies as well as develops medicines for patient with genetic diseases. The Company's product pipeline includes SB-525, SB-FIX, SB-318, SB-913, SB-728-T and SB-728-HSPC. Sangamo Therapeutics Inc.,...

See More

Key Turning Points

2nd Resistance Point 8.80
1st Resistance Point 8.56
Last Price 8.31
1st Support Level 8.17
2nd Support Level 8.03

See More

52-Week High 14.58
Fibonacci 61.8% 11.40
Fibonacci 50% 10.42
Fibonacci 38.2% 9.44
Last Price 8.31
52-Week Low 6.26

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar